Atlas Trials

A Study of Avastin (Bevacizumab) in Combination With Standard Therapy in Patients With Metastatic Renal Cell Cancer.

Clinical trial NCT00520403 · COMPLETED

Trial details

NCT number
NCT00520403
Sponsor
Hoffmann-La Roche
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Renal Cell Cancer
Start date
2007-09-01
Primary completion
2010-03-01
Enrollment
25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.